Health & Fitness
Hospitals have launched a lobbying blitz to stave off Trump administration rules they say will lose them hundreds of billions of dollars.
Roche built up its metabolic medicines pipeline with business deals, and its latest one gives…
Healthcare payers face growing FWA risks that are outpacing traditional controls. While recoveries remain important,…
At a moment when the country is debating everything from psychiatric overprescribing to the rise…
For a Fancy MealBrugarolA tiny restaurant with just a handful of tables, combining Japanese techniques…
AI tools aren’t free, and proving they’re worth the cost has been a sticking point…
Immunotherapy developer Abcuro received disappointing news this year as its lead drug candidate fell short…
